Shrimanker, I., & Bhattarai, S
Its availability exists in a highly restricted regulatory gray zone
However, an oral, daily semaglutide was also approved in 2019, under the name Rybelsus, and other companies have oral GLP-1s currently in their pipeline
It is also used in glutamate-cysteine ligase regulation and Nrf2/ARE pathway work, where glutathione acts as the feedback inhibitor of its own synthesis (Lu, Biochimica et Biophysica Acta, 2013)
The advent of ~15% average weight loss drugs has, for the first time, made many clinicians more optimistic about treating obesity as a chronic condition medically
This not only enhances their inflammatory potential but also affects antigen processing, glutathionylation of signaling proteins, and interactions with resident CNS cells such as microglia and astrocytes (Federici et al., 2024)